Delivery Order HHSN272201500005I-75N93021F00001
Award Date
12/15/20
Potential Completion Date
12/14/21
Potential Value
$136K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Dynport Vaccine Company LLC
Ultimate Awardee
General Dynamics Corp
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The $4,120,677 cost-plus-fixed-fee contract is for a Phase 1 clinical trial unit to support the development of therapeutics against infectious diseases. This award is part of the larger Therapeutics Against Infectious Diseases Phase 1 contract vehicle....
This federal contract award to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp, is in support of a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The $1,757,807.36 ceiling value contract was awarded on August 19, 2016 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is a delivery order against the $30 million Preclinical Services for Biopharmaceutical...
This is a $3,860,186.71 cost-plus-fixed-fee task order awarded to Dynport Vaccine Company LLC (DVC), a subsidiary of General Dynamics Corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The task order is for Phase 1 clinical trials of therapeutics against infectious diseases and was issued under the Therapeutics Against Infectious Diseases Phase 1 indefinite-delivery, indefinite-quantity...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $99,299 cost-plus-fixed-fee delivery order was placed under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase I clinical trials for therapeutic products targeting infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics...
This is a delivery order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery, indefinite quantity (IDIQ) contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The order, valued at $5,167,891.00, funds a Phase 1 clinical trial unit for therapeutic candidates against infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General...
This is a cost-plus-fixed-fee delivery order awarded to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $2,191,163 task order is part of the $346 million Early Phase Clinical Trial Units (EPCTU) indefinite-delivery, indefinite-quantity (IDIQ) contract, which funds Phase I clinical trial services. Dynport, a provider of research, development,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,500 firm fixed price delivery order contract to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation, for the Diagnostic Pre-Clinical Services Program. This contract is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle that provides funding for development processes needed to bring candidate infectious disease diagnostics to market. Dynport has previous experience...
This is a Delivery Order under the $3,500.00 Diagnostic Pre-Clinical Services Program IDIQ contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp that provides biopharmaceutical research, development, manufacturing, and testing services. This Delivery Order supports the development of candidate...
This is a $1,159,290,240.64 cost-plus-award-fee contract awarded by the Department of the Army Medical Command to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract, which has no set-aside designation, is for research, development, manufacturing, and testing services to support biopharmaceutical products targeting infectious diseases. Dynport has provided similar services under past federal contracts with NIH, HHS, and the Joint Program Executive Office for...
This is a $235,119,970.93 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The contract is for pandemic influenza preparedness and includes services such as preclinical development, clinical trials, diagnostic testing, vaccine stability evaluations, and cGMP production. The contract is not set aside and is a definitive contract rather than an indefinite delivery vehicle...